193 related articles for article (PubMed ID: 31340446)
1. Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse.
Nunes Dos Santos K; Florentino RM; França A; Lima Filho ACM; Santos MLD; Missiaggia D; Fonseca MC; Brasil Costa I; Vidigal PVT; Nathanson MH; Lemos FO; Leite MF
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340446
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Genetic Variations in
Santos LR; Durães C; Ziros PG; Pestana A; Esteves C; Neves C; Carvalho D; Bongiovanni M; Renaud CO; Chartoumpekis DV; Habeos IG; Simões MS; Soares P; Sykiotis GP
Thyroid; 2019 Sep; 29(9):1302-1315. PubMed ID: 31426718
[No Abstract] [Full Text] [Related]
3. Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations.
Song P; Li K; Liu L; Wang X; Jian Z; Zhang W; Wang G; Li C; Gao T
J Cell Mol Med; 2016 Oct; 20(10):1840-50. PubMed ID: 27222475
[TBL] [Abstract][Full Text] [Related]
4. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease.
Chen YC; Wu YR; Wu YC; Lee-Chen GJ; Chen CM
Parkinsonism Relat Disord; 2013 Feb; 19(2):247-50. PubMed ID: 23176750
[TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphism of the Nrf2 Promoter Region (rs35652124) Is Associated with the Risk of Diabetic Foot Ulcers.
Teena R; Dhamodharan U; Ali D; Rajesh K; Ramkumar KM
Oxid Med Cell Longev; 2020; 2020():9825028. PubMed ID: 32879654
[TBL] [Abstract][Full Text] [Related]
7. The Association of a Single-Nucleotide Polymorphism in the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene With Adverse Drug Reactions, Multimorbidity, and Frailty in Older People.
Scutt G; Overall A; Bakrania P; Krasteva E; Parekh N; Ali K; Davies JG; Rajkumar C
J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1050-1057. PubMed ID: 31102514
[TBL] [Abstract][Full Text] [Related]
8. Association of promoter methylation status of NRF2 and PNPLA3 genes in alcoholic liver disease.
M K S; Manrai M; Singh R; Mukherjee B; Mishra Y; Singh MU; Singh A; Negi R; Chandra GB; S V A; Misra P
Indian J Gastroenterol; 2022 Dec; 41(6):618-626. PubMed ID: 36652109
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive assessment of genetic sequence variants in the antioxidant 'master regulator' NRF2 in idiopathic Parkinson's disease.
Todorovic M; Newman JR; Shan J; Bentley S; Wood SA; Silburn PA; Mellick GD
PLoS One; 2015; 10(5):e0128030. PubMed ID: 26010367
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.
Nezi V; Deutsch M; Gazouli M; Alexopoulou A; Paparrigopoulos T; Liappas IA; Dourakis SP
Alcohol Clin Exp Res; 2013 Feb; 37(2):244-51. PubMed ID: 23009036
[TBL] [Abstract][Full Text] [Related]
11. Fibrogenesis in alcoholic liver disease.
Fujii H; Kawada N
World J Gastroenterol; 2014 Jul; 20(25):8048-54. PubMed ID: 25009376
[TBL] [Abstract][Full Text] [Related]
12. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease.
Korytina GF; Akhmadishina LZ; Aznabaeva YG; Kochetova OV; Zagidullin NS; Kzhyshkowska JG; Zagidullin SZ; Viktorova TV
Gene; 2019 Apr; 692():102-112. PubMed ID: 30641209
[TBL] [Abstract][Full Text] [Related]
13. Variants in the LGALS9 Gene Are Associated With Development of Liver Disease in Heavy Consumers of Alcohol.
Rosen HR; Golden-Mason L; Daly AK; Yang I; Day CP
Clin Gastroenterol Hepatol; 2016 May; 14(5):762-8.e1. PubMed ID: 26598225
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 in alcoholic liver disease.
Sun J; Fu J; Li L; Chen C; Wang H; Hou Y; Xu Y; Pi J
Toxicol Appl Pharmacol; 2018 Oct; 357():62-69. PubMed ID: 30165058
[TBL] [Abstract][Full Text] [Related]
15. The NFE2L2 rs35652124 polymorphism and the risk of Parkinson's disease: a systematic review and meta-analysis.
Zhu M; Zhou T; Zu G; Liang Z
Neuroreport; 2016 Aug; 27(12):901-5. PubMed ID: 27306592
[TBL] [Abstract][Full Text] [Related]
16. Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis.
Acosta-Herrera M; Pino-Yanes M; Blanco J; Ballesteros JC; Ambrós A; Corrales A; Gandía F; Subirá C; Domínguez D; Baluja A; Añón JM; Adalia R; Pérez-Méndez L; Flores C; Villar J;
Crit Care; 2015 Jun; 19(1):256. PubMed ID: 26077880
[TBL] [Abstract][Full Text] [Related]
17. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
Bergström P; von Otter M; Nilsson S; Nilsson AC; Nilsson M; Andersen PM; Hammarsten O; Zetterberg H
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):130-7. PubMed ID: 24102512
[TBL] [Abstract][Full Text] [Related]
18. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.
Liu Z; Yin X; Liu L; Tao H; Zhou H; Ma G; Cui L; Li Y; Zhang S; Xu Z; Yao L; Cai Z; Zhao B; Li K
Gene; 2015 Oct; 571(2):231-6. PubMed ID: 26149655
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury.
Lamlé J; Marhenke S; Borlak J; von Wasielewski R; Eriksson CJ; Geffers R; Manns MP; Yamamoto M; Vogel A
Gastroenterology; 2008 Apr; 134(4):1159-68. PubMed ID: 18395094
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.
Wang Z; Dou X; Li S; Zhang X; Sun X; Zhou Z; Song Z
Hepatology; 2014 Apr; 59(4):1381-92. PubMed ID: 24170703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
